| 标题 |
 A phase 1, open-label, multicenter, non-randomized study to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of AZD4573, a potent and selective CDK9 inhibitor, in subjects with relapsed or refractory hematological malignancies |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Simon Rule; Arnon P. Kater; Tim H. Brümmendorf; Chris Fegan; Martin Kaiser; et al 出版日期：2018-05-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
null
GingerF
kaio_escolar
OK
秦艽
忧心的曼凝
无极微光
mmmm
老迟到的涫
My_magnum_opus
Literature
cc
ohhh
DW
包容如雪
YYANG
年年有余
mmyhn
学霸业
Elsevier大王
皖公网安备34019202002308
